Una molécula para combatir una enfermedad rara, la PSP

from Biotecnología Capital · host Capital Radio

Oscar Pérez, Director de Desarrollo de Negocios y Alianzas Globales de Ferrer, nos cuenta la adquisición de los derechos a nivel mundial de una molécula de la suiza Asceneuron para tratar una enfermedad rara neurodegenerativa.

Episode metadata supplied by the publisher feed · Published Apr 27, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Una molécula para combatir una enfermedad rara, la PSP

0:00 14:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

DESCLASIFICACIÓN OVNI. LO QUE NOS OCULTAN LOS GOBIERNOS Y EL EJÉRCITO CON IKER JIMÉNEZ, JUANJO VALLEJO Y JUAN I. CUESTA

Nov 9, 2025 ·100m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biotecnología Capital?

This episode is 14 minutes long.

When was this Biotecnología Capital episode published?

This episode was published on April 27, 2025.

Can I download this Biotecnología Capital episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!